Phase I Trial of Humanized 1D10 Monoclonal Antibody (Hu1D10) In Patients With Relapsed Non-Hodgkin's Lymphoma (NHL).
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2013
At a glance
- Drugs Apolizumab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 08 Feb 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 13 Feb 2009 New trial record